BMJ Evidence-Based Medicine

Methylphenidate denied access to WHO’s list of essential medicines for the third time

Attention-deficit/hyperactivity disorder (ADHD) affects 3%–5% of children and about 2.5% of adults, though prevalence varies ...
ebm.bmj

181 The work of shared decision-making: a systematic review

6 Division of Health Care Delivery Research, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Rochester, USA 7 Division of Endocrinology, Diabetes, Metabolism, and ...
ebm.bmj

Wrong guidelines: why and how often they occur

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
ebm.bmj

Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health

Correspondence to Doctor Antoine Vanier, Health Technology Assessment Department, Haute Autorité de Santé, La Plaine Saint-Denis, 93210, France; a.vanier{at}has-sante.fr In France, decisions for ...
ebm.bmj

Review: avulsion with phenol prevents recurrence of ingrown toenails

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
ebm.bmj

011 Development and nation-wide implementation of a patient decision aid including real-world outcome information to support shared decision making about treatment for non ...

3 Department of Clinical Pharmacy, St. Antonius Hospital, Utrecht/Nieuwegein, The Netherlands 4 Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical ...
ebm.bmj

National Electronic Library for Health (NeLH)

The British National Electronic Library for Health aims to provide both healthcare professionals and the public with knowledge to support healthcare related decisions. This meta resource is ...
ebm.bmj

Opportunities, challenges and risks of using artificial intelligence for evidence synthesis

4 Institute of Medical Biometry and Statistics (IMBI), Medical Center – University of Freiburg, Faculty of Medicine, Freiburg, Germany 5 Eye Center, Medical Center, Faculty of Medicine, University of ...
ebm.bmj

Current knowledge on the adaptation of clinical practice guidelines: a scoping review

Background The adaptation of clinical practice guidelines (CPGs) is increasingly used to efficiently develop contextualised recommendations for local, regional and national settings. However, ...
ebm.bmj

Environmental Lessons Learned and Applied (ELLA): a new framework for identifying, prioritising and implementing decarbonisation interventions in clinical care pathways

A multidisciplinary framework for designing rapidly deployable, scalable and context-specific decarbonisation interventions for clinical care has been developed within the National Health Service, ...
ebm.bmj

Ataluren for Duchenne: how politics and social pressure undermined evidence-based decisions

Last 28 March 2025, the European Commission decided not to renew the conditional marketing authorisation for Translarna (ataluren) in Duchenne’s disease due to lack of efficacy after 11 years in the ...
ebm.bmj

How good is the evidence to support primary care practice?

Correspondence to Dr Mark H Ebell, Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, 125 Miller Hall, UGA Health Sciences Campus, Athens, GA 30602, USA; ...